Evaluation of In vitro anti urolithiasis activity of herbal drugs
Department of Pharmacognosy & Phytochemistry, K.L.E S’s college Of Pharmacy, Nipani, Karnataka, India.
Review
World Journal of Biology Pharmacy and Health Sciences, 2022, 12(02), 073–078.
Article DOI: 10.30574/wjbphs.2022.12.2.0168
Publication history:
Received on 20 September 2022; revised on 09 November 2022; accepted on 12 November 2022
Abstract:
Urinary stone disorder has afflicted human kind since antiquity and can persist, with serious medical consequences, throughout a patient’s lifetime. The common component of urinary stone is calcium oxalate (CaOx). In spite of tremendous advances in the field of medicine, there is no truly satisfactory drug for the treatment of renal calculi. In the indigenous system of medicine, the leaves Mentha piperita (family- Labiatae) Elettaria cardamom (zingiberaceae) and Syzygium cumini (family-Myrtaceae) are reported to be useful in the treatment of urinary stones. Hence, in the present study, the Mentha piperita, Elettaria cardamom and Syzygium cumini have been selected for their In vitro Antiurolithiatic activity on experimental kidney stones of calcium oxalate crystals.
Keywords:
Urolithiasis; Plant extracts; In vitro; Calcium oxalate crystals; Neeri standard drug
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0